Development and Validation of an Instrument Designed to Measure Factors Influencing Physician Prescribing Decisions

Overview

Journal Pharm Pract (Granada)

Date 2020 Jan 4

PMID 31897258

Citations 3

Authors

Mohsen Ali Murshid

Zurina Mohaidin

Mohammad Zayed

Affiliations

Soon will be listed here.

Abstract

Background: Previous attempts to develop an instrument to measure factors that influence prescribing decisions among physicians were relatively insufficient and lacked validation scale.

Objective: We present a new tool that attempts to address this shortcoming. Hence, this study aims to develop and validate a self-administrated instrument to explain factors that influence the prescribing decisions of physicians.

Methods: The questionnaire was developed based on literature and then subjected to an exhaustive assessment by a board of professionals and a pilot examination before being administered to 705 physicians. Three pre-tests were carried out to evaluate the quality of the survey items. In pre-test 1, after items are generated and the validity of their content is assessed by academics and physicians. In pre-test 2, the scale is carried out with a small sample of 20 respondents of physicians. In pre-test 3, fifty drop-off questionnaires were piloted amongst physicians to test the reliability.

Results: On the basis of partial least squares structural equation modelling (PLS-SEM) analyses using SmartPLS 3, the content and convergent validity of the instrument were confirmed with 44 items grouped into four categories, namely, marketing efforts, patient characteristics, pharmacist variables, and contextual factors with 13 reflective constructs.

Conclusions: The study outcomes prove that the scale is more valid and reliable for measuring factors that influence the decision of the physician to prescribe the drug. The development and presentation of a scale of thirteen factors related to physicians prescribing decisions help to ensure valid findings and facilitates comparisons of studies and research settings.

Citing Articles

Prescribing Trends and Associated Outcomes of Antiepileptic Drugs and Other Psychotropic Medications in US Nursing Homes: Proposal for a Mixed Methods Investigation.

Winter J, Kerns J, Brandt N, Wastila L, Qato D, Sabo R JMIR Res Protoc. 2024; 13:e64446.

PMID: 39298758 PMC: 11450359. DOI: 10.2196/64446.

Orthodontic patients and the information found on the web: a cross-sectional study.

Crispino R, Mannocci A, Dilena I, Sides J, Forchini F, Asif Alherawi W BMC Oral Health. 2023; 23(1):860.

PMID: 37957643 PMC: 10644509. DOI: 10.1186/s12903-023-03609-4.

Factors Influencing Physicians' Clinical Decision-making at Upazila Health Complexes in Bangladesh.

Islam M, Awal M Glob J Qual Saf Healthc. 2023; 3(4):125-133.

PMID: 37260574 PMC: 10229014. DOI: 10.36401/JQSH-20-7.

References

Shrank W, Joseph G, Choudhry N, Young H, Ettner S, Glassman P . Physicians' perceptions of relevant prescription drug costs: do costs to the individual patient or to the population matter most?. Am J Manag Care. 2006; 12(9):545-51. View

Theodorou M, Tsiantou V, Pavlakis A, Maniadakis N, Fragoulakis V, Pavi E . Factors influencing prescribing behaviour of physicians in Greece and Cyprus: results from a questionnaire based survey. BMC Health Serv Res. 2009; 9:150. PMC: 2737540. DOI: 10.1186/1472-6963-9-150. View

Mintzes B, Barer M, Kravitz R, Kazanjian A, Bassett K, Lexchin J . Influence of direct to consumer pharmaceutical advertising and patients' requests on prescribing decisions: two site cross sectional survey. BMJ. 2002; 324(7332):278-9. PMC: 65061. DOI: 10.1136/bmj.324.7332.278. View

Godin G, Belanger-Gravel A, Eccles M, Grimshaw J . Healthcare professionals' intentions and behaviours: a systematic review of studies based on social cognitive theories. Implement Sci. 2008; 3:36. PMC: 2507717. DOI: 10.1186/1748-5908-3-36. View

Liu Y, Doucette W, Farris K . Examining the development of pharmacist-physician collaboration over 3 months. Res Social Adm Pharm. 2010; 6(4):324-33. DOI: 10.1016/j.sapharm.2009.11.002. View

Van C, Costa D, Mitchell B, Abbott P, Krass I . Development and validation of a measure and a model of general practitioner attitudes toward collaboration with pharmacists. Res Social Adm Pharm. 2013; 9(6):688-99. DOI: 10.1016/j.sapharm.2012.12.005. View

Kersnik J, Peklar J . Attitudes of Slovene general practitioners towards generic drug prescribing and comparison with international studies. J Clin Pharm Ther. 2006; 31(6):577-83. DOI: 10.1111/j.1365-2710.2006.00776.x. View

Avkiran N . An in-depth discussion and illustration of partial least squares structural equation modeling in health care. Health Care Manag Sci. 2017; 21(3):401-408. DOI: 10.1007/s10729-017-9393-7. View

Wensing M, Broge B, Riens B, Kaufmann-Kolle P, Akkermans R, Grol R . Quality circles to improve prescribing of primary care physicians. Three comparative studies. Pharmacoepidemiol Drug Saf. 2009; 18(9):763-9. DOI: 10.1002/pds.1778. View

10.

Ostini R, Hegney D, Jackson C, Williamson M, Mackson J, Gurman K . Systematic review of interventions to improve prescribing. Ann Pharmacother. 2009; 43(3):502-13. DOI: 10.1345/aph.1L488. View

11.

Zillich A, Doucette W, Carter B, Kreiter C . Development and initial validation of an instrument to measure physician-pharmacist collaboration from the physician perspective. Value Health. 2005; 8(1):59-66. DOI: 10.1111/j.1524-4733.2005.03093.x. View

12.

Tahaineh L, Wazaify M, Albsoul-Younes A, Khader Y, Zaidan M . Perceptions, experiences, and expectations of physicians in hospital settings in Jordan regarding the role of the pharmacist. Res Social Adm Pharm. 2009; 5(1):63-70. DOI: 10.1016/j.sapharm.2008.05.003. View

13.

Clyne B, Fitzgerald C, Quinlan A, Hardy C, Galvin R, Fahey T . Interventions to Address Potentially Inappropriate Prescribing in Community-Dwelling Older Adults: A Systematic Review of Randomized Controlled Trials. J Am Geriatr Soc. 2016; 64(6):1210-22. DOI: 10.1111/jgs.14133. View

14.

Britten N, Ukoumunne O . The influence of patients' hopes of receiving a prescription on doctors' perceptions and the decision to prescribe: a questionnaire survey. BMJ. 1998; 315(7121):1506-10. PMC: 2127936. DOI: 10.1136/bmj.315.7121.1506. View

15.

Tusek-Bunc K, Kersnik J, Petek-Ster M, Petek D, Klemenc-Ketis Z . Explanatory model of prescribing behavior in prescription of statins in family practice. Wien Klin Wochenschr. 2010; 122 Suppl 2:79-84. DOI: 10.1007/s00508-010-1336-y. View

16.

Oshikoya K, Oreagba I, Adeyemi O . Sources of drug information and their influence on the prescribing behaviour of doctors in a teaching hospital in Ibadan, Nigeria. Pan Afr Med J. 2011; 9:13. PMC: 3215535. DOI: 10.4314/pamj.v9i1.71188. View

17.

Saito S, Mukohara K, Bito S . Japanese practicing physicians' relationships with pharmaceutical representatives: a national survey. PLoS One. 2010; 5(8):e12193. PMC: 2921334. DOI: 10.1371/journal.pone.0012193. View

18.

Kucukarslan S, Lai S, Dong Y, Al-Bassam N, Kim K . Physician beliefs and attitudes toward collaboration with community pharmacists. Res Social Adm Pharm. 2011; 7(3):224-32. DOI: 10.1016/j.sapharm.2010.07.003. View

19.

Basak R, Bentley J, McCaffrey 3rd D, Bouldin A, Banahan 3rd B . The role of perceived impact on relationship quality in pharmacists' willingness to influence indication-based off-label prescribing decisions. Soc Sci Med. 2015; 132:181-9. DOI: 10.1016/j.socscimed.2015.03.028. View

20.

Moore T, Kennedy J, McCarthy S . Exploring the General Practitioner-pharmacist relationship in the community setting in Ireland. Int J Pharm Pract. 2014; 22(5):327-34. DOI: 10.1111/ijpp.12084. View